Locations
South San Francisco, CA, USA · Del Mar, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2012
Antiva Biosciences is a biopharmaceutical company focused on developing novel topical therapies for treating pre-cancerous cervical lesions and HPV infections. Their innovative approach allows women to self-treat in the privacy of their homes, addressing a significant gap in current HPV treatment options. The company is dedicated to improving health outcomes globally and supports the World Health Organization’s initiative to eliminate cervical cancer. With a passionate team and a first-in-class therapy, Antiva aims to provide a non-surgical alternative for women with advanced disease, positioning itself as a leader in the HPV treatment market.
Something looks off?